Goodwin advised Germitec on the deal. Germitec, a global healthcare leader in high-Level UV-C disinfection systems, announced the financing round of €11 million. Reference investors in the...
You must be a Standard 1 Year member to access this content.
Aramis advised the sellers on the transaction. Exegy and Marlin Equity Partners were advised by Goodwin Procter. Exegy, a portfolio company of Marlin Equity Partners, a...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Kurma Partners, Bpifrance Investissement, BNP Paribas Développement and Majycc e-Santé Invest on the deal. Kurma Partners, Bpifrance Investissement, BNP Paribas Développement and Majycc...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Tikehau Ace Capital on the deal. Tikehau Ace Capital entered into exclusive negotiations to acquire 100% capital of ELVIA PCB. Founded in 1976, ELVIA...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Genfit on the deal. Genfit entered into a licensing agreement with Genoscience Pharma for exclusive right to develop and commercialize the investigational treatment...
You must be a Standard 1 Year member to access this content.
Dechert and Villey Girard Grolleaud advised Affluent Medical on the deal. Affluent Medical, a French medtech company specialising in urology and cardiology, executed its IPO on the...
You must be a Standard 1 Year member to access this content.
Bird & Bird advised Solaris Yachts, while Dechert advised Beneteau Group on the deal. Solaris Yachts executed the acquisition from Bénéteau S.A. and its subsidiary Construction Navale...
You must be a Standard 1 Year member to access this content.
Scotto Partners and Dechert advised Filippo Monteleone and Domnin de Kerdaniel on the deal. Domnin de KERDANIEL (CVC Capital Partners, 3i, KKR) and Filippo MONTELEONE, Founding...
You must be a Standard 1 Year member to access this content.
Dechert advised the investor on the deal. Kurma Partners, BNP Paribas Développement and Bpifrance through its fund Patient Autonomy, completed their investment of a total amount of...
You must be a Standard 1 Year member to access this content.
IN BRIEF: Allen & Overy, Dechert, advised on the matter. Allen & Overy advised Crédit Mutuel Equity with a team including Fr??ic Moreau (Corporate M&A), Romy...
You must be a Standard 1 Year member to access this content.
Dechert advised Biomunex Pharmaceuticals on the deal. Biomunex Pharmaceuticals, a French biopharmaceutical company, closed a strategic exclusive worldwide license and co-development agreement with Onward Therapeutics SA...
You must be a Standard 1 Year member to access this content.
